Atijosan Ayobami, Fajobi Abidemi


This study investigated from a gender perspective, analysis of the contributing factors to non-compliance of drug therapy among diabetes patients at Obafemi Awolowo University Teaching Hospital (OAUTHC), Ile-Ife, Nigeria. A self-designed questionnaire was administered and analysis was based on the 150 patients that agreed to participate in the study. Factors contributing to non-compliance with drug therapy observed in this study include; drug cost, care giving responsibilities, poor education, and the notion of feeling well. It was observed that 37.3% of female respondents compare to 27.3 % of male respondents, found it difficult to comply to their drug therapy due to high cost of the drugs. Also, 47.3% of female respondents compared to 10% of male respondents forgot to take their drugs due to child care giving responsibilities. Majority (52%) of female respondents compare to 18% of male respondents forgot to take their drugs due to the high demand of household chores. Furthermore, 32.7% of male respondents compared to female respondents (10.6%) forgot to take their drugs due to the notion that they are feeling well. The study concluded that gender gaps which hinder patients’ compliance to drug therapy should be bridged in order to improve the health care of women.


Gender; Drug Compliance; Diabetics; Gender Inequality; Diabetic Drugs

Full Text:



Abdulazeez, F. I., Omole, M., & Ojulari, S. L. (2014). Medication adherence amongst diabetic patients in a tertiary healthcare institution in central Nigeria. Tropical Journal of Pharmaceutical Research, 13(6), 997-1001.

Ajibade, B.L., Abdullahi.H., Ayodele,E.A (2010) factors militating against compliance with medical regimen among diabetic patients and implication for nursing practice in Osun State, Nigeria International Professional Journal, 8(1) htt://www.ionied.com

Alatorre, C., Fernández Landó, L., Yu, M., Brown, K., Montejano, L., Juneau, P., & Swindle, R. (2017). Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide. Diabetes, Obesity and Metabolism, 19(7), 953-961.

Awodele, O., & Osuolale, J. A. (2015). Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria. African Health Sciences, 15(2), 513-522.

Azuh, D. E., Amodu, L. O., Azuh, A. E., Oresanya, T., & Matthew, O. (2017). Factors of Gender Inequality and Development among Selected Low Human Development Countries in Sub- Saharan Africa. Journal Of Humanities And Social Science (JOSR-JHSS), 01-07.

Balkrishnan, R., Rajagopalan, R., Camacho, F.T., Huston, S.A., Murray, F.T, Anderson, R.T (2003). Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clinical Therapeutics. 25(11):2958–2971.

Banerji, M. A., & Dunn, J. D. (2013). Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes. American health & drug benefits, 6(7), 382.

Courtenay, W.H. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Social science & medicine. 2000; 50(10), pp.1385-1401.

Currie, C. J., Peyrot, M., Morgan, C. L., Poole, C. D., Jenkins-Jones, S., Rubin, R. R., & Evans, M. (2013). The impact of treatment non-compliance on mortality in people with type 1 diabetes. Journal of Diabetes and its Complications, 27(3), 219-223.

Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977-986.

Fadare, J., Olamoyegun, M., & Gbadegesin, B. A. (2015). Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi medical journal, 27(2), 65-70.

García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013). Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Therapy, 4(2), 175– 194. http://doi.org/10.1007/s13300-013-0034-y

Gelaw, B. K., Mohammed, A., Tegegne, G. T., Defersha, A. D., Fromsa, M., Tadesse, E., & Ahmed, M. (2014). Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital. Journal of diabetes research, 2014.

Gonzalez, J. S., Tanenbaum, M. L., & Commissariat, P. V. (2016). Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice. American Psychologist, 71(7), 539.

Heissam, K., Abuamer, Z., & El-Dahshan, N. (2015). Patterns and obstacles to oral antidiabetic medications adherence among Type 2 diabetics in Ismailia, Egypt: A cross section study. The Pan African Medical Journal, 20.

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., & Matthews, D. R. (2012). Management of hyperglycaemia in type 2 diabetes: a patient- centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 55(6), 1577- 1596.

Jha, A. K., Aubert, R. E., Yao, J., Teagarden, J. R., & Epstein, R. S. (2012). Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Affairs, 31(8), 1836-1846.

Kaufman, M. Men, feminism, and men's contradictory experiences of power. In: Brod, H., Kaufman, M. (Eds.), Theorising Masculinities. Sage Publications, Thousand Oaks, CA. 1994; pp. 142±163.

Kennedy-Martin, T., Boye, K. S., & Peng, X. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient preference and adherence, 11, 1103.

Mancini, F. R., Affret, A., Dow, C., Balkau, B., Bihan, H., Clavel-Chapelon, F., & Fagherazzi, G. (2017). Educational level and family structure influence the dietary changes after the diagnosis of type 2 diabetes: evidence from the E3N study. Nutrition Research, 44, 9-17.

Nazir, S. U. R., Hassali, M. A., Saleem, F., Bashir, S., & Aljadhey, H. (2016). Association Between Diabetes-related Knowledge and Medication Adherence: Results from Cross-sectional Analysis. Alternative therapies in health and medicine, 22(6), 8-13.

Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487-497.

Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Preference and Adherence, 10, 1299.

Rwegerera, G. M., Moshomo, T., Gaenamong, M., Oyewo, T. A., Gollakota, S., Mhimbira, F. A., & Rivera, Y. P. (2017). Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alexandria Journal of Medicine.

Sabaté, E. (Ed.). (2003). Adherence to long-term therapies: evidence for action. World Health Organization.

Sajith, M., Pankaj, M., Pawar, A., Modi, A., & Sumariya, R. (2014). Medication adherence to antidiabetic therapy in patients with type 2 diabetes mellitus. Young, 18(40), 7.

Schectman, J. M., Nadkarni, M. M., & Voss, J. D. (2002). The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care, 25(6), 1015-1021.

Shiyanbola, O. O., Brown, C. M., & Ward, E. C. (2018). “i did not want to take that medicine”: African-Americans’ reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence. Patient Preference and Adherence, 12, 409.

Shrestha, A. D., Kosalram, K., & Gopichandran, V. (2013). Gender difference in care of type 2 diabetes. Journal of the Nepal Medical Association, 52(189).

UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837-853.


  • There are currently no refbacks.

ISSN (Print): 2276-8645


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.